Allergan, Inc. News Headlines

AGN 
$184.9
*  
5.65
3.15%
Get AGN Alerts
*Delayed - data as of Oct. 21, 2014 10:49 ET  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Valeant Pharmaceuticals Makes Its Case With an Earnings Beat
10/21/2014 9:30:02 AM - Motley Fool


Digging Deeper Into Valeant's Organic Growth Claims
10/21/2014 7:14:00 AM - Seeking Alpha


Bloomberg: Actavis Among Final-stage Bidders For Omega Pharmaceuticals
10/20/2014 10:49:00 PM - RTT News


Medical Properties To Buy 40 Rehabilitation Hospitals In Germany For $900 Mln
10/20/2014 10:48:00 PM - RTT News


Can Valeant's Strong Q3 Entice Allergan?
10/20/2014 6:47:00 PM - Investor's Business Daily


Sanofi and Regeneron Dose Patients in Dupilumab Study - Analyst Blog
10/20/2014 5:45:00 PM - Zacks.com


Sector Update: Health Care Stocks Rising; Drug-Makers Said Still Talking Merger, Absent AbbVie
10/20/2014 1:56:44 PM - MT Newswires


Sector Update: Health Care
10/20/2014 1:50:43 PM - MT Newswires


Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners
10/20/2014 11:45:00 AM - TheStreet


Today's Market: Tech And Pharma Earnings Moving The Market
10/20/2014 9:45:00 AM - Seeking Alpha


U.S. Hot Stocks: Hot Stocks to Watch
10/20/2014 9:34:00 AM - Dow Jones Business News


Valeant Pharma Turns To Profit In Q3, Lifts 2014 Earnings Outlook
10/20/2014 8:50:00 AM - RTT News


Merger Arbitrage Carnage May Continue Due To AbbVie/Shire Inversion Fallout
10/17/2014 6:47:00 PM - Seeking Alpha


Healthcare Stocks in Focus on Ebola Fears - Analyst Blog
10/17/2014 2:34:00 PM - Zacks.com


Roche Reports Strong Sales Results for 9 Months of 2014 - Analyst Blog
10/17/2014 10:49:00 AM - Zacks.com


Sustainability Pays: 3 Green Companies Making Money
10/16/2014 11:00:02 AM - Motley Fool


XLV, MDT, LLY, AGN: Large Outflows Detected at ETF
10/16/2014 10:53:22 AM - BNK Invest


Aegon To Sell Canadian Operations - Quick Facts
10/16/2014 2:09:00 AM - RTT News


AbbVie's Humira Positive in Late-Stage Skin Disease Study - Analyst Blog
10/14/2014 6:05:00 PM - Zacks.com


J&J Beats Q3 Earnings on Strong Drug Sales, Ups View - Analyst Blog
10/14/2014 11:27:00 AM - Zacks.com


Time to Focus on Allergan (AGN) for Strong Earnings Growth Potential - Tale of the Tape
10/14/2014 8:58:00 AM - Zacks.com


Novartis Releases Data on Secukinumab for Plaque Psoriasis - Analyst Blog
10/13/2014 5:57:00 PM - Zacks.com


Ackman's Pershing Square Now Available To The Public
10/13/2014 4:41:00 PM - GuruFocus


10 Stocks Billionaire John Paulson Loves in 2014
10/13/2014 10:04:00 AM - TheStreet


Semiconductors Get Slammed As Investors Scramble To Protect Profits
10/13/2014 8:15:00 AM - Seeking Alpha